Scientists have discovered a potential biomarker that could more accurately identify which patients with non-hypermutated cancers will respond to specialized immunotherapy drugs called immune checkpoint inhibitors, according to findings published in Science Translational Medicine.
from News Medical Medical Research News Feed https://ift.tt/32xQqOT
0 Comments